Compare
West Pharmaceutical Services vs Dentsply Sirona (WST vs XRAY)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year West Pharmaceutical Services (WST) returned +41.0% and Dentsply Sirona (XRAY) -25.0%; so far this year the figures are +45.3% and -17.2%.
West Pharmaceutical Services is the larger company by market value, about 14.9 times the size of Dentsply Sirona.
Revenue grew +12.6% at WST and -1.4% at XRAY over the last year.
WST yields 0.22%. XRAY yields 1.69%.
Data as of the latest close. Not investment advice.
Relative performance
| WST | XRAY | |
|---|---|---|
| Price | $399.81 | $9.46 |
| 1-day | +1.87% | -6.24% |
| YTD | +45.31% | -17.24% |
| 1 year | +41.01% | -25.04% |
| 3 years | +24.29% | -69.33% |
| Market cap | $27.9B | $1.9B |
| P/E | 44.9 | — |
| P/S | 8.20 | 0.52 |
| P/B | 9.38 | 1.38 |
| Revenue growth | +12.60% | -1.40% |
| EPS growth | +32.00% | — |
| Gross margin % | 37.6 | 50.5 |
| Net margin % | 18.8 | -3.4 |
| ROE % | 21.5 | -8.9 |
| Debt / equity | 0.07 | 1.62 |
| FCF yield % | 1.6 | 5.5 |
| Dividend yield % | 0.22 | 1.69 |
| Beta | 0.66 | 1.17 |
| RSI (14) | 57.5 | 49.6 |
| Technical rating |